Share price of European biotechnology companies post-IPO performance in 2016

Published by Statista Research Department, May 15, 2016
This statistic presents the share price of leading European biotechnology companies post-IPO performance in 2016. The majority of biotechnology companies experience a fall in the share price post-IPO, however, Poxel biotechnology based in France experienced a 24 percent growth.

Leading European biotechnology companies by share price post-IPO in 2016

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

May 2016

Region

Europe

Survey time period

29th February 2016

Supplementary notes

* First venture round.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Biotechnology in Germany "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Biotechnology in Germany

Overview

8

Biopharmaceutical market

8

Research and components

6

Funding

4

Occupation

3

Further related statistics

8

Further Content: You might find this interesting as well

Statistics

Topics

Biotechnology industry in Germany Global pharmaceutical industryMedical technologyTop pharmaceutical drugsPharma e-commerce
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.